{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T15:26:33Z","timestamp":1775489193674,"version":"3.50.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.12736. BD"],"award-info":[{"award-number":["2022.12736. BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2022.12736. BD"],"award-info":[{"award-number":["2022.12736. BD"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["GHTMUID\/04413\/2020"],"award-info":[{"award-number":["GHTMUID\/04413\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["LA-REAL - LA\/P\/0117\/2020"],"award-info":[{"award-number":["LA-REAL - LA\/P\/0117\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"DOI":"10.1186\/s12936-024-05240-2","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T05:11:08Z","timestamp":1736485868000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low prevalence of copy number variation in pfmdr1 and pfpm2 in Plasmodium falciparum isolates from southern Angola"],"prefix":"10.1186","volume":"24","author":[{"given":"Denise","family":"Duarte","sequence":"first","affiliation":[]},{"given":"Francisco","family":"Manuel","sequence":"additional","affiliation":[]},{"given":"Ana","family":"Dias","sequence":"additional","affiliation":[]},{"given":"Esmeralda","family":"Sacato","sequence":"additional","affiliation":[]},{"given":"Elsa","family":"Taleingue","sequence":"additional","affiliation":[]},{"given":"Elsa","family":"Daniel","sequence":"additional","affiliation":[]},{"given":"Francisco","family":"Sim\u00e3o","sequence":"additional","affiliation":[]},{"given":"Luis","family":"Varandas","sequence":"additional","affiliation":[]},{"given":"Maria Lina","family":"Antunes","sequence":"additional","affiliation":[]},{"given":"Fatima","family":"Nogueira","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"5240_CR1","unstructured":"WHO. World malaria report 2023. Geneva, World Health Organization, 2023. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023."},{"key":"5240_CR2","doi-asserted-by":"crossref","unstructured":"Sacomboio ENM, dos Santos Sebasti\u00e3o C, Salvador ST da C, Jo\u00e3o JA, Bapolo DVS, Francisco NM, et al. Evaluation of blood cell count parameters as predictors of treatment failure of malaria in Angola: an observational study. PLoS One. 2022;17:e0267671.","DOI":"10.1371\/journal.pone.0267671"},{"key":"5240_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12936-022-04424-y","volume":"21","author":"W Tavares","year":"2022","unstructured":"Tavares W, Morais J, Martins JF, Scalsky RJ, Stabler TC, Medeiros MM, et al. Malaria in Angola: recent progress, challenges and future opportunities using parasite demography studies. Malar J. 2022;21:396.","journal-title":"Malar J"},{"key":"5240_CR4","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12936-017-1712-4","volume":"16","author":"MM Plucinski","year":"2017","unstructured":"Plucinski MM, Dimbu PR, Macaia AP, Ferreira CM, Samutondo C, Quivinja J, et al. Efficacy of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for treatment of uncomplicated Plasmodium falciparum malaria in Angola, 2015. Malar J. 2017;16:62.","journal-title":"Malar J"},{"key":"5240_CR5","unstructured":"White NJ. Malaria. In: Finch RG, Greenwood D, Norrby SR, Whitley RJ (eds.). Antibiotic and Chemotherapy. 9th Edn. Saunders Publ. 2010."},{"key":"5240_CR6","unstructured":"WHO. World malaria report 2021. Geneva, World Health Organization, 2021. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021. Accessed 30 Dec 2024."},{"key":"5240_CR7","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/d41591-024-00028-y","volume":"30","author":"DS Ishengoma","year":"2024","unstructured":"Ishengoma DS, Gosling R, Martinez-Vega R, Beshir KB, Bailey JA, Chimumbwa J, et al. Urgent action is needed to confront artemisinin partial resistance in African malaria parasites. Nat Med. 2024;30:1807\u20138.","journal-title":"Nat Med"},{"key":"5240_CR8","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s15010-018-1174-9","volume":"46","author":"G Russo","year":"2018","unstructured":"Russo G, L\u2019Episcopia M, Menegon M, Souza SS, Dongho BGD, Vullo V, et al. Dihydroartemisinin\u2013piperaquine treatment failure in uncomplicated Plasmodium falciparum malaria case imported from Ethiopia. Infection. 2018;46:867\u201370.","journal-title":"Infection"},{"key":"5240_CR9","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1186\/s12936-016-1572-3","volume":"15","author":"F Gobbi","year":"2016","unstructured":"Gobbi F, Buonfrate D, Menegon M, Lunardi G, Angheben A, Severini C, et al. Failure of dihydroartemisinin-piperaquine treatment of uncomplicated Plasmodium falciparum malaria in a traveller coming from Ethiopia. Malar J. 2016;15:525.","journal-title":"Malar J"},{"key":"5240_CR10","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1016\/S0140-6736(18)30291-5","volume":"391","author":"I Sagara","year":"2018","unstructured":"Sagara I, Beavogui AH, Zongo I, Soulama I, Borghini-Fuhrer I, Fofana B, et al. Pyronaridine\u2013artesunate or dihydroartemisinin\u2013piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b\/4 trial. Lancet. 2018;391:1378\u201390.","journal-title":"Lancet"},{"key":"5240_CR11","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01525-23","volume":"68","author":"PR Dimbu","year":"2024","unstructured":"Dimbu PR, Labuda S, Ferreira CM, Caquece F, Andr\u00e9 K, Pembele G, et al. Therapeutic response to four artemisinin-based combination therapies in Angola, 2021. Antimicrob Agents Chemother. 2024;68: e0152523.","journal-title":"Antimicrob Agents Chemother"},{"key":"5240_CR12","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1016\/S0140-6736(12)60484-X","volume":"379","author":"AP Phyo","year":"2012","unstructured":"Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. Lancet. 2012;379:1960\u20136.","journal-title":"Lancet"},{"key":"5240_CR13","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","volume":"17","author":"M Imwong","year":"2017","unstructured":"Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis. 2017;17:491\u20137.","journal-title":"Lancet Infect Dis"},{"key":"5240_CR14","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","volume":"361","author":"AM Dondorp","year":"2009","unstructured":"Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361:455\u201367.","journal-title":"N Engl J Med"},{"key":"5240_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ijid.2021.07.008","volume":"110","author":"A Silva-Pinto","year":"2021","unstructured":"Silva-Pinto A, Domingos J, Cardoso M, Reis A, Benavente ED, Caldas JP, et al. Artemether-lumefantrine treatment failure of uncomplicated Plasmodium falciparum malaria in travellers coming from Angola and Mozambique. Int J Infect Dis. 2021;110:151\u20134.","journal-title":"Int J Infect Dis"},{"key":"5240_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1038\/nm.4381","volume":"23","author":"B Blasco","year":"2017","unstructured":"Blasco B, Leroy D, Fidock DA. Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic. Nat Med. 2017;23:917\u201328.","journal-title":"Nat Med"},{"key":"5240_CR17","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","volume":"371","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411\u201323.","journal-title":"N Engl J Med"},{"key":"5240_CR18","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1128\/AAC.06350-11","volume":"56","author":"MI Veiga","year":"2012","unstructured":"Veiga MI, Ferreira PE, Malmberg M, J\u00f6rnhagen L, Bj\u00f6rkman A, Nosten F, et al. pfmdr1 amplification is related to increased Plasmodium falciparum in vitro sensitivity to the bisquinoline piperaquine. Antimicrob Agents Chemother. 2012;56:3615\u20139.","journal-title":"Antimicrob Agents Chemother"},{"key":"5240_CR19","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","volume":"17","author":"R Amato","year":"2017","unstructured":"Amato R, Lim P, Miotto O, Amaratunga C, Dek D, Pearson RD, et al. Genetic markers associated with dihydroartemisinin\u2013piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype\u2013phenotype association study. Lancet Infect Dis. 2017;17:164\u201373.","journal-title":"Lancet Infect Dis"},{"key":"5240_CR20","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1093\/infdis\/jiu141","volume":"210","author":"MD Conrad","year":"2014","unstructured":"Conrad MD, LeClair N, Arinaitwe E, Wanzira H, Kakuru A, Bigira V, et al. Comparative impacts over 5 years of artemisinin-based combination therapies on Plasmodium falciparum polymorphisms that modulate drug sensitivity in Ugandan Children. J Infect Dis. 2014;210:344\u201353.","journal-title":"J Infect Dis"},{"key":"5240_CR21","doi-asserted-by":"crossref","unstructured":"Taylor AR, Flegg JA, Holmes CC, Gu\u00e9rin PJ, Sibley CH, Conrad MD, et al. Artemether-lumefantrine and dihydroartemisinin-piperaquine exert inverse selective pressure on Plasmodium falciparum drug sensitivity-associated haplotypes in Uganda. Open Forum Infect Dis. 2017;4:ofw229.","DOI":"10.1093\/ofid\/ofw229"},{"key":"5240_CR22","doi-asserted-by":"crossref","unstructured":"Cal\u00e7ada C, Silva M, Baptista V, Thathy V, Silva-Pedrosa R, Granja D, et al. Expansion of a specific Plasmodium falciparum PfMDR1 Haplotype in Southeast Asia with increased substrate transport. mBio. 2020;11:e02093\u201320.","DOI":"10.1128\/mBio.02093-20"},{"key":"5240_CR23","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41467-018-04104-z","volume":"9","author":"S Bopp","year":"2018","unstructured":"Bopp S, Magistrado P, Wong W, Schaffner SF, Mukherjee A, Lim P, et al. Plasmepsin II\u2013III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum. Nat Commun. 2018;9:1769.","journal-title":"Nat Commun"},{"key":"5240_CR24","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","volume":"17","author":"B Witkowski","year":"2017","unstructured":"Witkowski B, Duru V, Khim N, Ross LS, Saintpierre B, Beghain J, et al. A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype\u2013genotype association study. Lancet Infect Dis. 2017;17:174\u201383.","journal-title":"Lancet Infect Dis"},{"key":"5240_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.915656","volume":"12","author":"R Kubota","year":"2022","unstructured":"Kubota R, Ishino T, Iwanaga S, Shinzawa N. Evaluation of the effect of gene duplication by genome editing on drug resistance in Plasmodium falciparum. Front Cell Infect Microbiol. 2022;12: 915656.","journal-title":"Front Cell Infect Microbiol"},{"key":"5240_CR26","doi-asserted-by":"publisher","first-page":"13419","DOI":"10.1038\/s41598-021-92735-6","volume":"11","author":"N Boonyalai","year":"2021","unstructured":"Boonyalai N, Thamnurak C, Sai-ngam P, Ta-aksorn W, Arsanok M, Uthaimongkol N, et al. Plasmodium falciparum phenotypic and genotypic resistance profile during the emergence of Piperaquine resistance in Northeastern Thailand. Sci Rep. 2021;11:13419.","journal-title":"Sci Rep"},{"key":"5240_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S1473-3099(23)00502-9","volume":"24","author":"C Florimond","year":"2024","unstructured":"Florimond C, de Laval F, Early AM, Sauthier S, Lazrek Y, Pelleau S, et al. Impact of piperaquine resistance in Plasmodium falciparum on malaria treatment effectiveness in The Guianas: a descriptive epidemiological study. Lancet Infect Dis. 2024;24:161\u201371.","journal-title":"Lancet Infect Dis"},{"key":"5240_CR28","first-page":"186","volume":"21","author":"S Moss","year":"2022","unstructured":"Moss S, Ma\u0144ko E, Krishna S, Campino S, Clark TG, Last A. How has mass drug administration with dihydroartemisinin-piperaquine impacted molecular markers of drug resistance? A systematic review Malar J. 2022;21:186.","journal-title":"A systematic review Malar J"},{"key":"5240_CR29","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4269\/ajtmh.2012.12-0058","volume":"87","author":"AW Maiga","year":"2012","unstructured":"Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, et al. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. Am J Trop Med Hyg. 2012;87:23\u20138.","journal-title":"Am J Trop Med Hyg"},{"key":"5240_CR30","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4269\/ajtmh.14-0605","volume":"92","author":"A Ouattara","year":"2015","unstructured":"Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, et al. Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara. Mali Am J Trop Med Hyg. 2015;92:1202\u20136.","journal-title":"Mali Am J Trop Med Hyg"},{"key":"5240_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","volume":"505","author":"F Ariey","year":"2014","unstructured":"Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois A-C, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50\u20135.","journal-title":"Nature"},{"key":"5240_CR32","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/nar\/gky1268","volume":"47","author":"AC Huckaby","year":"2019","unstructured":"Huckaby AC, Granum CS, Carey MA, Szlachta K, Al-Barghouthi B, Wang Y-H, et al. Complex DNA structures trigger copy number variation across the Plasmodium falciparum genome. Nucleic Acids Res. 2019;47:1615\u201327.","journal-title":"Nucleic Acids Res"},{"key":"5240_CR33","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/mmi.12162","volume":"88","author":"A Heinberg","year":"2013","unstructured":"Heinberg A, Siu E, Stern C, Lawrence EA, Ferdig MT, Deitsch KW, et al. Direct evidence for the adaptive role of copy number variation on antifolate susceptibility in Plasmodium falciparum. Mol Microbiol. 2013;88:702\u201312.","journal-title":"Mol Microbiol"},{"key":"5240_CR34","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.pt.2009.04.005","volume":"25","author":"TJC Anderson","year":"2009","unstructured":"Anderson TJC, Patel J, Ferdig MT. Gene copy number and malaria biology. Trends Parasitol. 2009;25:336\u201343.","journal-title":"Trends Parasitol"},{"key":"5240_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003375","volume":"9","author":"JL Guler","year":"2013","unstructured":"Guler JL, Freeman DL, Ahyong V, Patrapuvich R, White J, Gujjar R, et al. Asexual populations of the human malaria parasite, Plasmodium falciparum, use a two-step genomic strategy to acquire accurate, beneficial DNA amplifications. PLoS Pathog. 2013;9: e1003375.","journal-title":"PLoS Pathog"},{"key":"5240_CR36","doi-asserted-by":"crossref","unstructured":"Huntley BJ. Angola in outline: physiography, climate and patterns of biodiversity. Biodiversity of Angola. Cham: Springer International Publishing; 2019. p. 15\u201342.","DOI":"10.1007\/978-3-030-03083-4_2"},{"key":"5240_CR37","doi-asserted-by":"crossref","unstructured":"Figueiredo P, Benchimol C, Lopes D, Bernardino L, do Ros\u00e1rio VE, Varandas L, et al. Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola. Malar J. 2008;7:236.","DOI":"10.1186\/1475-2875-7-236"},{"key":"5240_CR38","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/1475-2875-9-361","volume":"9","author":"A Rosanas-Urgell","year":"2010","unstructured":"Rosanas-Urgell A, Mueller D, Betuela I, Barnadas C, Iga J, Zimmerman PA, et al. Comparison of diagnostic methods for the detection and quantification of the four sympatric Plasmodium species in field samples from Papua New Guinea. Malar J. 2010;9:361.","journal-title":"Malar J"},{"key":"5240_CR39","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12936-020-03249-x","volume":"19","author":"MR Ansbro","year":"2020","unstructured":"Ansbro MR, Jacob CG, Amato R, Kekre M, Amaratunga C, Sreng S, et al. Development of copy number assays for detection and surveillance of piperaquine resistance associated plasmepsin 2\/3 copy number variation in Plasmodium falciparum. Malar J. 2020;19:181.","journal-title":"Malar J"},{"key":"5240_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1186\/s12936-016-1258-x","volume":"15","author":"J Beghain","year":"2016","unstructured":"Beghain J, Langlois A-C, Legrand E, Grange L, Khim N, Witkowski B, et al. Plasmodium copy number variation scan: gene copy numbers evaluation in haploid genomes. Malar J. 2016;15:206.","journal-title":"Malar J"},{"key":"5240_CR41","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ijpddr.2021.03.001","volume":"15","author":"SC Nkhoma","year":"2021","unstructured":"Nkhoma SC, Ahmed AOA, Zaman S, Porier D, Baker Z, Stedman TT. Dissection of haplotype-specific drug response phenotypes in multiclonal malaria isolates. Int J Parasitol Drugs Drug Resist. 2021;15:152\u201361.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"5240_CR42","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00346-24","volume":"68","author":"N Brown","year":"2024","unstructured":"Brown N, da Silva C, Webb C, Matias D, Dias B, Cancio B, et al. Antimalarial resistance risk in Mozambique detected by a novel quadruplex droplet digital PCR assay. Antimicrob Agents Chemother. 2024;68: e0034624.","journal-title":"Antimicrob Agents Chemother"},{"key":"5240_CR43","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1128\/AAC.03265-14","volume":"59","author":"M Chugh","year":"2015","unstructured":"Chugh M, Scheurer C, Sax S, Bilsland E, van Schalkwyk DA, Wicht KJ, et al. Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains. Antimicrob Agents Chemother. 2015;59:1110\u20138.","journal-title":"Antimicrob Agents Chemother"},{"key":"5240_CR44","doi-asserted-by":"publisher","first-page":"5408","DOI":"10.1128\/AAC.05102-11","volume":"55","author":"NB Gadalla","year":"2011","unstructured":"Gadalla NB, Adam I, Elzaki S-E, Bashir S, Mukhtar I, Oguike M, et al. Increased pfmdr1 copy number and sequence polymorphisms in Plasmodium falciparum isolates from Sudanese malaria patients treated with artemether-lumefantrine. Antimicrob Agents Chemother. 2011;55:5408\u201311.","journal-title":"Antimicrob Agents Chemother"},{"key":"5240_CR45","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12936-019-2756-4","volume":"18","author":"D Leroy","year":"2019","unstructured":"Leroy D, Macintyre F, Adoke Y, Ouoba S, Barry A, Mombo-Ngoma G, et al. African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker. Malar J. 2019;18:126.","journal-title":"Malar J"},{"key":"5240_CR46","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods. 2001;25:402\u20138.","journal-title":"Methods"},{"key":"5240_CR47","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1186\/s12936-017-1868-y","volume":"16","author":"CN Nguetse","year":"2017","unstructured":"Nguetse CN, Adegnika AA, Agbenyega T, Ogutu BR, Krishna S, Kremsner PG, et al. Molecular markers of anti-malarial drug resistance in Central, West and East African children with severe malaria. Malar J. 2017;16:217.","journal-title":"Malar J"},{"key":"5240_CR48","doi-asserted-by":"publisher","first-page":"3049","DOI":"10.1128\/AAC.00209-10","volume":"54","author":"B Witkowski","year":"2010","unstructured":"Witkowski B, Nicolau M-L, Soh PN, Iriart X, Menard S, Alvarez M, et al. Plasmodium falciparum isolates with increased pfmdr1 copy number circulate in West Africa. Antimicrob Agents Chemother. 2010;54:3049\u201351.","journal-title":"Antimicrob Agents Chemother"},{"key":"5240_CR49","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1128\/AAC.04181-14","volume":"59","author":"MM Plucinski","year":"2015","unstructured":"Plucinski MM, Talundzic E, Morton L, Dimbu PR, Macaia AP, Fortes F, et al. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for treatment of uncomplicated malaria in children in Zaire and U\u00edge Provinces. Angola Antimicrob Agents Chemother. 2015;59:437\u201343.","journal-title":"Angola Antimicrob Agents Chemother"},{"key":"5240_CR50","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12936-018-2290-9","volume":"17","author":"E Davlantes","year":"2018","unstructured":"Davlantes E, Dimbu PR, Ferreira CM, Florinda Joao M, Pode D, F\u00e9lix J, et al. Efficacy and safety of artemether\u2013lumefantrine, artesunate\u2013amodiaquine, and dihydroartemisinin\u2013piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2017. Malar J. 2018;17:144.","journal-title":"Malar J"},{"key":"5240_CR51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s12936-018-2233-5","volume":"17","author":"D Ljolje","year":"2018","unstructured":"Ljolje D, Dimbu PR, Kelley J, Goldman I, Nace D, Macaia A, et al. Prevalence of molecular markers of artemisinin and lumefantrine resistance among patients with uncomplicated Plasmodium falciparum malaria in three provinces in Angola, 2015. Malar J. 2018;17:84.","journal-title":"Malar J"},{"key":"5240_CR52","doi-asserted-by":"crossref","unstructured":"Kiaco K, Teixeira J, Machado M, do Ros\u00e1rio V, Lopes D. Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola. Malar J. 2015;14:504.","DOI":"10.1186\/s12936-015-1018-3"},{"key":"5240_CR53","doi-asserted-by":"crossref","unstructured":"Asua V, Vinden J, Conrad MD, Legac J, Kigozi SP, Kamya MR, et al. Changing molecular markers of antimalarial drug sensitivity across Uganda. Antimicrob Agents Chemother. 2019;63.","DOI":"10.1128\/AAC.01818-18"},{"key":"5240_CR54","doi-asserted-by":"crossref","unstructured":"Mvumbi DM, Bobanga TL, Kayembe J-MN, Mvumbi GL, Situakibanza HN-T, Benoit-Vical F, et al. Molecular surveillance of Plasmodium falciparum resistance to artemisinin-based combination therapies in the Democratic Republic of Congo. PLoS One. 2017;12:e0179142.","DOI":"10.1371\/journal.pone.0179142"},{"key":"5240_CR55","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14787210.2017.1313703","volume":"15","author":"JP Gil","year":"2017","unstructured":"Gil JP, Krishna S. pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies. Expert Rev Anti Infect Ther. 2017;15:527\u201343.","journal-title":"Expert Rev Anti Infect Ther"},{"key":"5240_CR56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3201\/eid2401.170864","volume":"24","author":"H Gupta","year":"2017","unstructured":"Gupta H, Macete E, Bulo H, Salvador C, Warsame M, Carvalho E, et al. Drug-resistant polymorphisms and copy numbers in Plasmodium falciparum, Mozambique, 2015. Emerg Infect Dis. 2017;24:40\u20138.","journal-title":"Emerg Infect Dis"},{"key":"5240_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0240174","volume":"15","author":"H Gupta","year":"2020","unstructured":"Gupta H, Galatas B, Chidimatembue A, Huijben S, Cister\u00f3 P, Matambisso G, et al. Effect of mass dihydroartemisinin\u2013piperaquine administration in southern Mozambique on the carriage of molecular markers of antimalarial resistance. PLoS ONE. 2020;15: e0240174.","journal-title":"PLoS ONE"},{"key":"5240_CR58","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1186\/s12916-022-02652-2","volume":"20","author":"DM Wakoli","year":"2022","unstructured":"Wakoli DM, Ondigo BN, Ochora DO, Amwoma JG, Okore W, Mwakio EW, et al. Impact of parasite genomic dynamics on the sensitivity of Plasmodium falciparum isolates to piperaquine and other antimalarial drugs. BMC Med. 2022;20:448.","journal-title":"BMC Med"},{"key":"5240_CR59","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1093\/infdis\/jix334","volume":"216","author":"S Agrawal","year":"2017","unstructured":"Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, et al. Association of a novel mutation in the Plasmodium falciparum chloroquine resistance transporter with decreased piperaquine sensitivity. J Infect Dis. 2017;216:468\u201376.","journal-title":"J Infect Dis"},{"key":"5240_CR60","doi-asserted-by":"crossref","unstructured":"Kane J, Li X, Kumar S, Button-Simons KA, Vendrely Brenneman KM, Dahlhoff H, et al. A Plasmodium falciparum genetic cross reveals the contributions of pfcrt and plasmepsin II\/III to piperaquine drug resistance. mBio. 2024;15:e0080524","DOI":"10.1128\/mbio.00805-24"},{"key":"5240_CR61","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.1193225","volume":"329","author":"M Rottmann","year":"2010","unstructured":"Rottmann M, McNamara C, Yeung BKS, Lee MCS, Zou B, Russell B, et al. Spiroindolones, a potent compound class for the treatment of malaria. Science. 2010;329:1175\u201380.","journal-title":"Science"},{"key":"5240_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/expr.2001.4618","volume":"98","author":"S Thaithong","year":"2001","unstructured":"Thaithong S, Ranford-Cartwright LC, Siripoon N, Harnyuttanakorn P, Kanchanakhan NS, Seugorn A, et al. Plasmodium falciparum: gene mutations and amplification of dihydrofolate reductase genes in parasites grown in vitro in presence of pyrimethamine. Exp Parasitol. 2001;98:59\u201370.","journal-title":"Exp Parasitol"},{"key":"5240_CR63","unstructured":"Phillips MA, Lotharius J, Marsh K, White J, Dayan A, White KL, et al. A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria. Sci Transl Med. 2015;7:296ra111."},{"key":"5240_CR64","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1038\/ng2042","volume":"39","author":"DF Conrad","year":"2007","unstructured":"Conrad DF, Hurles ME. The population genetics of structural variation. Nat Genet. 2007;39:S30\u20136.","journal-title":"Nat Genet"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12936-024-05240-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-024-05240-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T06:04:27Z","timestamp":1736489067000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-024-05240-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5240"],"URL":"https:\/\/doi.org\/10.1186\/s12936-024-05240-2","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"6 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"DNA samples were collected following individual oral consent and signed informed written consent from all participants or their guardians. Ethical clearance for the work was obtained from: Comit\u00e9 de \u00c9tica Independente da Faculdade de Medicina da Universidade Agostinho Neto and by the Hospital Central Dr. Ant\u00f3nio Agostinho Neto (HCL) institutional ethics review committee (deliberation N\u00ba08\/2020, on 14 November 2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}